A carregar...
Dimebon disappointment
Dimebon (latrepirdine) has received widespread publicity as a potential therapy for Alzheimer's disease following a very positive phase 2 study carried out in Russia and published in the Lancet in 2008. In this study there were improvements over 6 months in all endpoints (cognitive, global, dai...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2983434/ https://ncbi.nlm.nih.gov/pubmed/20836898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt49 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|